Halozyme Therapeutics reported $6.47B in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 3.91B 222.46M
Agios Pharmaceuticals AGIO:US $ 3.39B 211.72M
Alnylam Pharmaceuticals ALNY:US $ 19.93B 3.36B
Amarin AMRN:US 1.73B 715.38M
Amgen AMGN:US $ 140.05B 3.22B
Aptinyx Inc APTX:US $ 192.93M 7.74M
Arena Pharmaceuticals ARNA:US $ 4.16B 41.38M
Baxter International BAX:US $ 40.48B 2.18B
Cara Therapeutics CARA:US $ 714.24M 368.58M
Cytokinetics CYTK:US $ 1.42B 244.24M
Dbv Technologies DBVT:US 604.54M 27.99M
Eli Lilly And LLY:US $ 220.12B 40.96B
Esperion Therapeutics ESPR:US $ 596.26M 193.51M
Five Prime Therapeutics FPRX:US $ 1.77B 1.02B
Halozyme Therapeutics HALO:US $ 6.47B 491.5M
Immunogen IMGN:US $ 1.32B 300.21M
Intercept Pharmaceuticals ICPT:US $ 663.03M 98.97M
Intra Cellular Therapies ITCI:US $ 3.32B 573.64M
Intrexon XON:US $ 1.35B 76.37M
IONIS PHARMACEUT IONS:US $ 5.62B 710.4M
JAZZ PHA JAZZ:US 10.83B 1.57B
Mannkind MNKD:US $ 1.36B 384.05M
Minerva Neurosciences NERV:US $ 99.11M 25.63M
Nektar Therapeutics NKTR:US $ 3.13B 515.22M
Peregrine Pharmaceuticals PPHM:US $ 1.57B 458.25M
Pfizer PFE:US $ 219205.69M 17108.81M
Rigel Pharmaceuticals RIGL:US $ 738.51M 156.7M
United Therapeutics UTHR:US $ 8.04B 550.55M
Vanda Pharmaceuticals VNDA:US $ 1.2B 370.85M